WNT1 and Parkinson disease: Similar to our study, Wei et al. reported that activation of the Wnt/β-catenin signaling pathway with exogenous Wnt1 could protect the SH-SY5Y cell line against 6-hydroxydopamine, which is another kind of in vitro PD model [32].